Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 2
This trial looked at olaparib for non small cell lung cancer (NCSLC) that had spread to another part of the body. It was supported by Cancer Research UK.
The trial was open for people to join between 2014 and 2017, and the team presented the results in 2020.
Recruitment start: 28 January 2014
Recruitment end: 30 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Dean Fennell
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Velindre NHS Trust
This is Cancer Research UK trial number CRUK/11/055.
Last reviewed: 19 May 2021
CRUK internal database number: 9186
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
